Zanmei Xu

PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC

Xiuchao Wang, Xin Li, Xunbin Wei et al. · Signal Transduction and Targeted Therapy · 2020 · 131 citations · Full text

<i>miR‐22</i><b>enhances the radiosensitivity of small‐cell lung cancer by targeting the</b><i>WRNIP1</i>

Wenhua Jiang, Xuemei Han, Jingrui Wang et al. · Journal of Cellular Biochemistry · 2019 · 37 citations · Full text

Somatic gene mutation signatures predict cancer type and prognosis in multiple cancers with pan-cancer 1000 gene panel

Hailong Wang, Pengfei Liu, Jie Yue et al. · Cancer Letters · 2019 · 26 citations

Somatic Variant, Gene Panel, Tumor Heterogeneity +11

GISTs with NTRK Gene Fusions: A Clinicopathological, Immunophenotypic, and Molecular Study

Zi Cao, Jiaxin Li, Lin Sun et al. · Cancers · 2022 · 24 citations · Full text

Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor

Wenxian Wang, Qian Wang, C. Xu et al. · Thoracic Cancer · 2022 · 19 citations · Full text

Immunodeficiencies, Immunology, Immunoediting +20